BioMarin Pharmaceutical Inc. buy Truist Financial Co.
Start price
13.07.23
/
50%
€76.16
Target price
13.07.24
€125.20
Performance (%)
3.31%
End price
14.07.24
€78.68
Summary
This prediction ended on 14.07.24 with a price of €78.68. The BUY prediction by Truist_Financial_Co_ finished with a performance of 3.31%. Truist_Financial_Co_ has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 0.878% | 0.878% | -1.164% |
| iShares Core DAX® | -0.612% | 0.567% | 12.585% |
| iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% |
| iShares Nikkei 225® | -2.647% | 0.330% | 9.482% |
| iShares S&P 500 | -1.932% | -1.126% | 23.191% |
Comments by Truist_Financial_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Truist Financial Co. from $125.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.68
15.09.23
15.09.23
€131.12
15.09.24
15.09.24
-4.52%
25.07.24
25.07.24
Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.00
25.09.23
25.09.23
€131.92
25.09.24
25.09.24
-4.89%
25.07.24
25.07.24